• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
SGEN

SGEN

Seagen Inc.

NASDAQHealthcareBiotechnologyUS

USD228.74

-0.16 (-0.07%)

Company Profile

CEO

David R. Epstein

IPO Date

2001-03-09

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$228.93

Prev. Close

$228.90

Day Low

$228.74

Day High

$228.96

52W Low

$126.47

52W High

$228.96

Market Cap

$43.15B

Volume

19.39M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentNeutral

Articles

10

Avg Positive

26.6%

Avg Negative

33.9%

Avg Neutral

39.7%

News Feed

Federal Circuit Court of Appeals Vacates Infringement Judgment and Damages Award in Dispute between Daiichi Sankyo and Seagen

businesswire.com·12/3/2025·↓ negative

Pres. Trump's push to lower drug prices 'is a good starting point', says Dr. Scott Gottlieb

youtube.com·8/1/2025·↓ negative

President Trump demands drugmakers slash prices within 60 days

youtube.com·8/1/2025·↓ negative

Refractory Metastatic Melanoma Pipeline Report 2025, with Focus on BioNTech SE, Y-mAbs and Therapeutics Seagen

globenewswire.com·3/20/2025·↑ positive

Two Brothers, a Big Biotech Bet and an $8 Billion Payout

wsj.com·4/13/2024·↓ negative

Pfizer: Seagen Acquisition Starting To Bear Fruit

seekingalpha.com·3/12/2024·↑ positive

Pfizer to close Seagen manufacturing plant in Seattle area following $43B acquisition

geekwire.com·3/2/2024·↓ negative

Pfizer CEO doubles down on 2024 guidance, talks Seagen buy

Yahoo Finance·1/30/2024·↑ positive

Cramer names biopharma companies to watch as industry mergers start to pile up

cnbc.com·1/5/2024·↑ positive

5 Biotech Acquisition Targets To Accumulate In 2024

seekingalpha.com·12/21/2023·↓ negative